Cited by 761Adipokines, Inflammation, and Metabolic DiseasesCardiovascular Disease and AdiposityAdipose Tissue and Metabolism

The DOI matches its Crossref record; 118 of the 121 references it cites were found in a registry or an index.

Minireview: Adiposity, Inflammation, and Atherogenesis

Lyon, Christopher J., Law, Ronald E., Hsueh, Willa A.·2003·Endocrinology

DOI 10.1210/en.2003-0285

Open this paper in CoChat — free account

Abstract

Adipose tissue is a dynamic endocrine organ that secretes a number of factors that are increasingly recognized to contribute to systemic and vascular inflammation. Several of these factors, collectively referred to as adipokines, have now been shown regulate, directly or indirectly, a number of the processes that contribute to the development of atherosclerosis, including hypertension, endothelial dysfunction, insulin resistance, and vascular remodeling. Several adipokines are preferentially expressed in visceral adipose tissue, and the secretion of proinflammatory adipokines is elevated with increasing adiposity. Not surprisingly, approaches that reduce adipose tissue depots, including surgical fat removal, exercise, and reduced caloric intake, improve proinflammatory adipokine levels and reduce the severity of their resultant pathologies. Systemic adipokine levels can also be favorably altered by treatment with several of the existing drug classes used to treat insulin resistance, hypertension, and hypercholesterolemia. Greater understanding of adipokine regulation, however, should result in the design of improved treatment strategies to control disease states associated with increase adiposity, an important outcome in view of the growing worldwide epidemic of obesity.

Integrity signals

Registry

Crossref · 10.1210/en.2003-0285

Cites

118 of 118 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women
Ridker, P. M., Hennekens, C. H., Buring, J. E., & Rifai, N. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003233421202 · Cited by 5,850
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P., & Hennekens, C. H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704033361401 · Cited by 5,504
Cardiovascular morbidity and mortality in the losartan intervention for endpoint reduction in hypertension study (LIFE): A randomised trial against atenolol
Dahlöf, B., Devereux, R. B., Kjeldsen, S. E., Julius, S., Beevers, G., de Faire, U., Fyhrquist, F., Ibsen, H., Kristiansson, K., Lederballe-Pedersen, O., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08089-3 · Cited by 5,407
The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men
Lakka, H.-M. (2002) · JAMA · doi:10.1001/jama.288.21.2709 · Cited by 5,033
The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity
Yamauchi, T., Kamon, J., Waki, H., Terauchi, Y., Kubota, N., Hara, K., Mori, Y., Ide, T., Murakami, K., Tsuboyama-Kasaoka, N., et al. (2001) · Nature Medicine · doi:10.1038/90984 · Cited by 4,915
Paradoxical Decrease of an Adipose-Specific Protein, Adiponectin, in Obesity
Arita, Y., Kihara, S., Ouchi, N., Takahashi, M., Maeda, K., Miyagawa, J.-I., Hotta, K., Shimomura, I., Nakamura, T., Miyaoka, K., et al. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0255 · Cited by 4,856
The hormone resistin links obesity to diabetes
Steppan, C. M., Bailey, S. T., Bhat, S., Brown, E. J., Banerjee, R. R., Wright, C. M., Patel, H. R., Ahima, R. S., & Lazar, M. A. (2001) · Nature · doi:10.1038/35053000 · Cited by 4,755
Comparison of C-Reactive Protein and Low-Density Lipoprotein Cholesterol Levels in the Prediction of First Cardiovascular Events
Ridker, P. M., Rifai, N., Rose, L., Buring, J. E., & Cook, N. R. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021993 · Cited by 3,604
C-Reactive Protein in Healthy Subjects: Associations With Obesity, Insulin Resistance, and Endothelial Dysfunction: A Potential Role for Cytokines Originating From Adipose Tissue?
Yudkin, J. S., Stehouwer, C. D. A., Emeis, J. J., & Coppack, S. W. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.4.972 · Cited by 2,465
Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase.
Xie, Q. W., Kashiwabara, Y., & Nathan, C. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37600-7 · Cited by 2,212
Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression
Lord, G. M., Matarese, G., Howard, J. K., Baker, R. J., Bloom, S. R., & Lechler, R. I. (1998) · Nature · doi:10.1038/29795 · Cited by 2,178
Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?
Yudkin, J. S., Kumari, M., Humphries, S. E., & Mohamed-Ali, V. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00463-3 · Cited by 1,775
Omental and Subcutaneous Adipose Tissues of Obese Subjects Release Interleukin-6: Depot Difference and Regulation by Glucocorticoid
Fried, S. K., Bunkin, D. A., & Greenberg, A. S. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.3.4660 · Cited by 1,756
Adiponectin, an Adipocyte-Derived Plasma Protein, Inhibits Endothelial NF-κB Signaling Through a cAMP-Dependent Pathway
Ouchi, N., Kihara, S., Arita, Y., Okamoto, Y., Maeda, K., Kuriyama, H., Hotta, K., Nishida, M., Takahashi, M., Muraguchi, M., et al. (2000) · Circulation · doi:10.1161/01.cir.102.11.1296 · Cited by 1,730
PPARγ Ligands Increase Expression and Plasma Concentrations of Adiponectin, an Adipose-Derived Protein
Maeda, N., Takahashi, M., Funahashi, T., Kihara, S., Nishizawa, H., Kishida, K., Nagaretani, H., Matsuda, M., Komuro, R., Ouchi, N., et al. (2001) · Diabetes · doi:10.2337/diabetes.50.9.2094 · Cited by 1,673
Adipose Tissue as an Endocrine Organ
Ahima, R. S., & Flier, J. S. (2000) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(00)00301-5 · Cited by 1,608
Absence of Monocyte Chemoattractant Protein-1 Reduces Atherosclerosis in Low Density Lipoprotein Receptor–Deficient Mice
Gu, L., Okada, Y., Clinton, S. K., Gerard, C. J., Sukhova, G. K., Libby, P., & Rollins, B. J. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80139-2 · Cited by 1,574
ENDOGENOUS NITRIC OXIDE INHIBITS HUMAN PLATELET ADHESION TO VASCULAR ENDOTHELIUM
Radomski, M. W., Palmer, R. M. J., & Moncada, S. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91481-4 · Cited by 1,437
Preservation of Pancreatic β-Cell Function and Prevention of Type 2 Diabetes by Pharmacological Treatment of Insulin Resistance in High-Risk Hispanic Women
Buchanan, T. A., Xiang, A. H., Peters, R. K., Kjos, S. L., Marroquin, A., Goico, J., Ochoa, C., Tan, S., Berkowitz, K., Hodis, H. N., et al. (2002) · Diabetes · doi:10.2337/diabetes.51.9.2796 · Cited by 1,339
Novel Risk Factors for Systemic Atherosclerosis
Ridker, P. M., Stampfer, M. J., & Rifai, N. (2001) · JAMA · doi:10.1001/jama.285.19.2481 · Cited by 1,290
Leptin-Replacement Therapy for Lipodystrophy
Oral, E. A., Simha, V., Ruiz, E., Andewelt, A., Premkumar, A., Snell, P., Wagner, A. J., DePaoli, A. M., Reitman, M. L., Taylor, S. I., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012437 · Cited by 1,247
A major role for VCAM-1, but not ICAM-1, in early atherosclerosis
Cybulsky, M. I., Iiyama, K., Li, H., Zhu, S.-N., Chen, M., Iiyama, M., Davis, V., Gutierrez-Ramos, J.-C., Connelly, P. W., & Milstone, D. S. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11871 · Cited by 1,244
Weight Reduction Increases Plasma Levels of an Adipose-Derived Anti-Inflammatory Protein, Adiponectin
Yang, W.-S., Lee, W.-J., Funahashi, T., Tanaka, S., Matsuzawa, Y., Chao, C.-L., Chen, C.-L., Tai, T.-Y., & Chuang, L.-M. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.8.3815 · Cited by 1,181
Adiponectin Reduces Atherosclerosis in Apolipoprotein E-Deficient Mice
Okamoto, Y., Kihara, S., Ouchi, N., Nishida, M., Arita, Y., Kumada, M., Ohashi, K., Sakai, N., Shimomura, I., Kobayashi, H., et al. (2002) · Circulation · doi:10.1161/01.cir.0000042707.50032.19 · Cited by 1,036
Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines
Frostegård, J., Ulfgren, A., Nyberg, P., Hedin, U., Swedenborg, J., Andersson, U., & Hansson, G. K. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(99)00011-8 · Cited by 1,002
Reduction of Inflammatory Cytokine Concentrations and Improvement of Endothelial Functions in Obese Women After Weight Loss Over One Year
Ziccardi, P., Nappo, F., Giugliano, G., Esposito, K., Marfella, R., Cioffi, M., D’Andrea, F., Molinari, A. M., & Giugliano, D. (2002) · Circulation · doi:10.1161/hc0702.104279 · Cited by 994
Effect of Rosiglitazone Treatment on Nontraditional Markers of Cardiovascular Disease in Patients With Type 2 Diabetes Mellitus
Haffner, S. M., Greenberg, A. S., Weston, W. M., Chen, H., Williams, K., & Freed, M. I. (2002) · Circulation · doi:10.1161/01.cir.0000025403.20953.23 · Cited by 881
Pravastatin and the Development of Diabetes Mellitus: Evidence for a Protective Treatment Effect in the West of Scotland Coronary Prevention Study
Freeman, D. J., Norrie, J., Sattar, N., Neely, R. D. G., Cobbe, S. M., Ford, I., Isles, C., Lorimer, A. R., Macfarlane, P. W., McKillop, J. H., et al. (2001) · Circulation · doi:10.1161/01.cir.103.3.357 · Cited by 844
Acute-phase response of human hepatocytes: Regulation of acute-phase protein synthesis by interleukin-6
Castell, J. V., Gómez-Lechón, M. J., David, M., Fabra, R., Trullenque, R., & Heinrich, P. C. (1990) · Hepatology · doi:10.1002/hep.1840120517 · Cited by 759
C-Reactive Protein Is an Independent Predictor of Risk for the Development of Diabetes in the West of Scotland Coronary Prevention Study
Freeman, D. J., Norrie, J. D., CASLAKE, M. J., Gaw, A., Ford, I., Lowe, G. D. O., O’Reilly, D. S. J., Packard, C. J., Sattar, N. A., & for the West of Scotland Coronary Prevention Study Group (2002) · Diabetes · doi:10.2337/diabetes.51.5.1596 · Cited by 727
The Effect of Thiazolidinediones on Plasma Adiponectin Levels in Normal, Obese, and Type 2 Diabetic Subjects
Yu, J. G., Javorschi, S., Hevener, A. L., Kruszynska, Y. T., Norman, R. A., Sinha, M. K., & Olefsky, J. M. (2002) · Diabetes · doi:10.2337/diabetes.51.10.2968 · Cited by 726
Chronic Leptin Infusion Increases Arterial Pressure
Shek, E. W., Brands, M. W., & Hall, J. E. (1998) · Hypertension · doi:10.1161/01.hyp.31.1.409 · Cited by 686
Changing concepts of atherogenesis
Libby, P. (2000) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2000.00654.x · Cited by 626
High Plasminogen Activator Inhibitor and Tissue Plasminogen Activator Levels in Plasma Precede a First Acute Myocardial Infarction in Both Men and Women: Evidence for the Fibrinolytic System as an Independent Primary Risk Factor
Thögersen, A. M., Jansson, J.-H., Boman, K., Nilsson, T. K., Weinehall, L., Huhtasaari, F., & Hallmans, G. (1998) · Circulation · doi:10.1161/01.cir.98.21.2241 · Cited by 602
Tumor necrosis factor-alpha suppresses insulin-induced tyrosine phosphorylation of insulin receptor and its substrates.
Feinstein, R., Kanety, H., Papa, M. Z., Lunenfeld, B., & Karasik, A. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)74276-8 · Cited by 545
Ramipril and the Development of Diabetes
Yusuf, S. (2001) · JAMA · doi:10.1001/jama.286.15.1882 · Cited by 541
Hyperinsulinemia, Hyperglycemia, and Impaired Hemostasis
Meigs, J. B., Mittleman, M. A., Nathan, D. M., Tofler, G. H., Singer, D. E., Murphy-Sheehy, P., Lipinska, I., D’Agostino, R. B., & Wilson, P. W. F. (2000) · JAMA · doi:10.1001/jama.283.2.221 · Cited by 536
Prospective Study of C-Reactive Protein in Relation to the Development of Diabetes and Metabolic Syndrome in the Mexico City Diabetes Study
Han, T. S., Sattar, N. A., Williams, K., González‐Villalpando, C., Lean, M. E. J., & Haffner, S. M. (2002) · Diabetes Care · doi:10.2337/diacare.25.11.2016 · Cited by 512
Exercise training enhances endothelial function in young men
Clarkson, P., Montgomery, H., Mullen, M., Donald, A. E., Powe, A. J., Bull, T., Jubb, M., WORLD, M. J., & Deanfield, J. E. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00036-4 · Cited by 466
Risk of new-onset diabetes in the Losartan Intervention For Endpoint reduction in hypertension study
Lindholm, L. H., Ibsen, H., Borch-Johnsen, K., Olsen, M. H., Wachtell, K., Dahlöf, B., Devereux, R. B., Beevers, G., de Faire, U., Fyhrquist, F., et al. (2002) · Journal of Hypertension · doi:10.1097/00004872-200209000-00035 · Cited by 392
Troglitazone Inhibits Formation of Early Atherosclerotic Lesions in Diabetic and Nondiabetic Low Density Lipoprotein Receptor–Deficient Mice
Collins, A. R., Meehan, W. P., Kintscher, U., Jackson, S. M., Wakino, S., Noh, G. J., Palinski, W., Hsueh, W. A., & Law, R. E. (2001) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.21.3.365 · Cited by 389
Self-citation
Endothelial Dysfunction: Cause of the Insulin Resistance Syndrome
Pinkney, J. H., Stehouwer, C. D. A., Coppack, S. W., & Yudkin, J. S. (1997) · Diabetes · doi:10.2337/diab.46.2.s9 · Cited by 350
Absence of CC chemokine receptor-2 reduces atherosclerosis in apolipoprotein E-deficient mice
Dawson, T. C., Kuziel, W. A., Osahar, T. A., & Maeda, N. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(98)00318-9 · Cited by 340
Role of macrophage colony-stimulating factor in atherosclerosis: studies of osteopetrotic mice.
Qiao, J. H., Tripathi, J., Mishra, N. K., Cai, Y., Tripathi, S., Wang, X. P., Imes, S., Fishbein, M. C., Clinton, S. K., Libby, P., et al. (1997) · Europe PMC (PubMed Central) · Cited by 327
Differences in mRNA expression of the proteins secreted by the adipocytes in human subcutaneous and visceral adipose tissues
Dusserre, E., Moulin, P., & Vidal, H. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(99)00091-5 · Cited by 326
Enhanced endothelial adhesiveness in hypercholesterolemia is attenuated by L-arginine.
Tsao, P. S., McEvoy, L. M., Drexler, H., Butcher, E. C., & Cooke, J. P. (1994) · Circulation · doi:10.1161/01.cir.89.5.2176 · Cited by 324
Troglitazone Inhibits Atherosclerosis in Apolipoprotein E–Knockout Mice
Chen, Z., Ishibashi, S., Perrey, S., Osuga, J.-I., Gotoda, T., Kitamine, T., Tamura, Y., Okazaki, H., Yahagi, N., Iizuka, Y., et al. (2001) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.21.3.372 · Cited by 323
Cytokine induction of monocyte chemoattractant protein‐1 gene expression in human endothelial cells depends on the cooperative action of NF‐χB and AP‐1
Martin, T., Cardarelli, P. M., Parry, G. C., Felts, K. A., & Cobb, R. R. (1997) · European Journal of Immunology · doi:10.1002/eji.1830270508 · Cited by 317
Elevated Expression of Transforming Growth Factor-β in Adipose Tissue from Obese Mice
Samad, F., Yamamoto, K., Pandey, M., & Loskutoff, D. J. (1997) · Molecular Medicine · doi:10.1007/bf03401666 · Cited by 303
Obstructive uropathy in the mouse: Role of osteopontin in interstitial fibrosis and apoptosis
Ophascharoensuk, V., Giachelli, C. M., GORDON, K. L., Hughes, J., Pichler, R. H., Brown, P. A., Liaw, L., Schmidt, R., Shankland, S. J., Alpers, C. E., et al. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00580.x · Cited by 294
Angiotensin II is associated with activation of NF-κB-mediated genes and downregulation of PPARs
Tham, D. M., Martin-McNulty, B., Wang, Y.-X., Wilson, D. W., Vergona, R. A., Sullivan, M. E., Dole, W. P., & Rutledge, J. C. (2002) · Physiological Genomics · doi:10.1152/physiolgenomics.00062.2002 · Cited by 279
PAI-1 deficiency attenuates the fibrogenic response to ureteral obstruction
Oda, T., Jung, Y. O., Kim, H. S., Cai, X., López-Guisa, J. M., Ikeda, Y., & Eddy, A. A. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.030002587.x · Cited by 274
Direct Demonstration of P-Selectin– and VCAM-1–Dependent Mononuclear Cell Rolling in Early Atherosclerotic Lesions of Apolipoprotein E–Deficient Mice
Ramos, C. L., Huo, Y., Jung, U., Ghosh, S., Manka, D. R., Sarembock, I. J., & Ley, K. F. (1999) · Circulation Research · doi:10.1161/01.res.84.11.1237 · Cited by 272
Bleomycin-induced pulmonary fibrosis in fibrinogen-null mice
Hattori, N., Degen, J. L., Sisson, T. H., Liu, H., Moore, B. B., Pandrangi, R. G., Simon, R. H., & Drew, A. F. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10531 · Cited by 264
Angiotensin II induces plasminogen activator inhibitor-1 and -2 expression in vascular endothelial and smooth muscle cells.
Feener, E. P., Northrup, J. M., Aiello, L. P., & King, G. L. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117786 · Cited by 254
The adhesion molecules used by monocytes for migration across endothelium include CD11a/CD18, CD11b/CD18, and VLA-4 on monocytes and ICAM-1, VCAM-1, and other ligands on endothelium.
Meerschaert, J., & Furie, M. B. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.8.4099 · Cited by 237
Adipose tissue secretion of plasminogen activator inhibitor-1 in non-obese and obese individuals
Eriksson, P. O., Reynisdottir, S., Lönnqvist, F., Stemme, V., Hamsten, A., & Arner, P. (1998) · Diabetologia · doi:10.1007/s001250050868 · Cited by 228
Impact of weight loss on plasminogen activator inhibitor (PAI-1), factor VII, and other hemostatic factors in moderately overweight adults.
Folsom, A. R., Qamhieh, H. T., Wing, R. R., Jeffery, R. W., Stinson, V., Kuller, L. H., & Wu, K. K. (1993) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.13.2.162 · Cited by 224
Relationships between plasma insulin triglyceride, body mass index, and plasminogen activator inhibitor 1.
Juhan-Vague, I., Vague, P., Alessi, M., Badier, C., Valadier, J., Aillaud, M.-F., & Atlan, C. (1987) · PubMed · Cited by 218
Roles of Angiotensin II Type 2 Receptor Stimulation Associated With Selective Angiotensin II Type 1 Receptor Blockade With Valsartan in the Improvement of Inflammation-Induced Vascular Injury
Wu, L., Iwai, M., Hironori Nakagami, A., Li, Z., Chen, R., Suzuki, J., Akishita, M., Marc De Gasparo, B., & Horiuchi, M. (2001) · Circulation · doi:10.1161/hc4601.099404 · Cited by 217
C-Reactive Protein Is an Independent Predictor of the Rate of Increase in Early Carotid Atherosclerosis
Hashimoto, H., Kitagawa, K., Hougaku, H., Shimizu, Y., Sakaguchi, M., Nagai, Y., Iyama, S., Yamanishi, H., Matsumoto, M., & Hori, M. (2001) · Circulation · doi:10.1161/hc2601.091705 · Cited by 215
Activation of the NF-kappa B and I kappa B system in smooth muscle cells after rat arterial injury. Induction of vascular cell adhesion molecule-1 and monocyte chemoattractant protein-1.
Landry, D. B., Couper, L. L., Bryant, S. R., & Lindner, V. (1997) · PubMed Central · Cited by 205
Overexpression of the Renin-Angiotensin System in Human Visceral Adipose Tissue in Normal and Overweight Subjects
Giacchetti, G., Faloia, E., Mariniello, B., Sardu, C., Gatti, C., Camilloni, M. A., Guerrieri, M., & Mantero, F. (2002) · American Journal of Hypertension · doi:10.1016/s0895-7061(02)02257-4 · Cited by 202
Tissue Distribution and Regulation of Plasminogen Activator Inhibitor-1 in Obese Mice
Samad, F., & Loskutoff, D. J. (1996) · Molecular Medicine · doi:10.1007/bf03401641 · Cited by 191
C-Reactive Protein Predicts Progression of Atherosclerosis Measured at Various Sites in the Arterial Tree
van der Meer, I. M., de Maat, M. P. M., Hak, A. E., Kiliaan, A. J., del Sol, A. I., van der Kuip, D. A. M., Nijhuis, R. L. G., Albert Hofman, D., & Witteman, J. C. M. (2002) · Stroke · doi:10.1161/01.str.0000044168.00485.02 · Cited by 186
The thiazolidinedione rosiglitazone (BRL-49653) lowers blood pressure and protects against impairment of endothelial function in Zucker fatty rats.
Walker, A. B., Chattington, P., Buckingham, R. E., & Williams, G. (1999) · Diabetes · doi:10.2337/diabetes.48.7.1448 · Cited by 185
Associations of Fibrinogen, Factor VII and PAI-1 with Baseline Findings among 10,500 Male Participants in a Prospective Study of Myocardial Infarction
Aillaud, M.-F., Amouyel, P., Evans, A., Luc, G., Ferrières, J., Arveiler, D., Juhan-Vague, I., & Scarabin, P. (1998) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1615353 · Cited by 184
Plasminogen activator inhibitor-1 deficiency protects against atherosclerosis progression in the mouse carotid artery
Eitzman, D. T., Westrick, R. J., Xu, Z., Tyson, J. A., & Ginsburg, D. (2000) · Blood · doi:10.1182/blood.v96.13.4212 · Cited by 182
NAD(P)H Oxidase-derived Hydrogen Peroxide Mediates Endothelial Nitric Oxide Production in Response to Angiotensin II
Cai, H. “., Li, Z., Dikalov, S., Holland, S. M., Hwang, J., Jo, H., Dudley, S. C., & Harrison, D. G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m208884200 · Cited by 182
Nitric Oxide Inhibits Macrophage-Colony Stimulating Factor Gene Transcription in Vascular Endothelial Cells
Peng, H., Rajavashisth, T. B., Libby, P., & Liao, J. K. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.28.17050 · Cited by 177
Tumor Necrosis Factor- in Sera of Obese Patients: Fall with Weight Loss
Dandona, P. (1998) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.8.2907 · Cited by 176
Down-regulation of the Expression of the Obese Gene by an Antidiabetic Thiazolidinedione in Zucker Diabetic Fatty Rats and db/db Mice
Zhang, B., Graziano, M. P., Doebber, T. W., Leibowitz, M. D., White-Carrington, S., Szalkowski, D., Hey, P. J., Wu, M. S., Cullinan, C. A., Bailey, P., et al. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.16.9455 · Cited by 172
Effects of exercise rehabilitation on endothelial reactivity in older patients with peripheral arterial disease
Brendle, D. C., Joseph, L., Corretti, M. C., Gardner, A. W., & Katzel, L. I. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(00)01367-9 · Cited by 166
Increased Plasminogen Activator Inhibitor-1 and Vasculopathy
Sobel, B. E. (1999) · Circulation · doi:10.1161/01.cir.99.19.2496 · Cited by 159
Plasminogen Activator Inhibitor-1 Deficiency Prevents Hypertension and Vascular Fibrosis in Response to Long-term Nitric Oxide Synthase Inhibition
Kaikita, K., Fogo, A. B., Ma, L., Schoenhard, J. A., Brown, N. J., & Vaughan, D. E. (2001) · Circulation · doi:10.1161/hc3301.092803 · Cited by 159
Hypertriglyceridemia and regulation of fibrinolytic activity.
Mussoni, L., Mannucci, L., Sirtori, M., Camera, M., MADERNA, P., Sironi, L., & Tremoli, E. (1992) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.12.1.19 · Cited by 155
Angiotensin II and Its Metabolites Stimulate PAI-1 Protein Release From Human Adipocytes in Primary Culture
Skurk, T., Lee, Y., & Hauner, H. (2001) · Hypertension · doi:10.1161/01.hyp.37.5.1336 · Cited by 150
Leptin Acts in the Central Nervous System to Produce Dose-Dependent Changes in Arterial Pressure
Correia, M., Morgan, D. A., Sivitz, W. I., Mark, A. L., & Haynes, W. G. (2001) · Hypertension · doi:10.1161/01.hyp.37.3.936 · Cited by 146
Thrombogenic and Fibrinolytic Factors and Cardiovascular Risk in Non-insulin-dependent Diabetes Mellitus
Juhan-Vague, I., Alessi, M., & Vague, P. (1996) · Annals of Medicine · doi:10.3109/07853899608999095 · Cited by 142
Comparative Effect of Angiotensin-Converting Enzyme Inhibition and Angiotensin II Type 1 Receptor Antagonism on Plasma Fibrinolytic Balance in Humans
Brown, N. J., Agirbasli, M., & Vaughan, D. E. (1999) · Hypertension · doi:10.1161/01.hyp.34.2.285 · Cited by 124
Angiotensin II Increases Urokinase-Type Plasminogen Activator Expression and Induces Aneurysm in the Abdominal Aorta of Apolipoprotein E-Deficient Mice
Wang, Y., Martin-McNulty, B., Freay, A. D., Sukovich, D. A., Halks‐Miller, M., Li, W., Vergona, R. A., Sullivan, M. E., Morser, J., Dole, W. P., et al. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62532-1 · Cited by 122
Post‐challenge hyperglycaemia relates more strongly than fasting hyperglycaemia with carotid intima‐media thickness: the RIAD Study
Hanefeld, M., Koehler, C., Henkel, E., Fuecker, K., Schäper, F., & Temelkova-Kurktschiev, T. S. (2000) · Diabetic Medicine · doi:10.1046/j.1464-5491.2000.00408.x · Cited by 118
Do ACE‐inhibitors suppress tumour necrosis factor‐α production in advanced chronic renal failure?
Stenvinkel, P., Andersson, P., Wang, T., Lindholm, B., Bergström, J. P., Palmblad, J. E. W., Heimbürger, O., & Cederholm, T. (1999) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1999.00560.x · Cited by 118
Glucose-dependent Regulation of Cholesterol Ester Metabolism in Macrophages by Insulin and Leptin
O’Rourke, L., Grønning, L. M., Yeaman, S. J., & Shepherd, P. R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202151200 · Cited by 118
Fibrate and Statin Synergistically Increase the Transcriptional Activities of PPARα/RXRα and Decrease the Transactivation of NFκB
Inoue, I., Itoh, F., Aoyagi, S., Tazawa, S., Kusama, H., Akahane, M., Mastunaga, T., Hayashi, K., Awata, T., Komoda, T., et al. (2002) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.6141 · Cited by 116
Correction of diet-induced hyperglycemia, hyperinsulinemia, and skeletal muscle insulin resistance by moderate hyperleptinemia
Buettner, R., Newgard, C. B., Rhodes, C. J., & O'Doherty, R. M. (2000) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2000.278.3.e563 · Cited by 111
Reduction in Factor VII, Fibrinogen and Plasminogen Activator Inhibitor-1 Activity after Surgical Treatment of Morbid Obesity
Primrose, J. M., Davies, J. A., Prentice, C. R. M., Hughes, R., & Johnston, D. A. (1992) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1646284 · Cited by 105
Interaction of Very Late Antigen-4 with VCAM-1 Supports Transendothelial Chemotaxis of Monocytes by Facilitating Lateral Migration
Weber, C., & Springer, T. A. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.12.6825 · Cited by 97
Transcriptional Activation of the Macrophage-Colony Stimulating Factor Gene by Minimally Modified LDL
Rajavashisth, T. B., Yamada, H., & Mishra, N. K. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.10.1591 · Cited by 96
Regional Variation in Plasminogen Activator Inhibitor-1 Expression in Adipose Tissue from Obese Individuals
Harmelen, V. V., Hoffstedt, J., Lundquist, P., Vidal, H., Stemme, V., Hamsten, A., Arner, P., Reynisdottir, S., & Eriksson, P. (2000) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613860 · Cited by 88
Angiotensin converting enzyme inhibitors suppress production of tumor necrosis factor-α in vitro and in vivo
Fukuzawa, M., Satoh, J., Sagara, M., Muto, G., Muto, Y., Nishimura, S., Miyaguchi, S., Qiang, X., Sakata, Y., NAKAZAWA, T., et al. (1997) · Immunopharmacology · doi:10.1016/s0162-3109(96)00160-9 · Cited by 87
Vascular cell adhesion molecule 1: contrasting transcriptional control mechanisms in muscle and endothelium.
Iademarco, M. F., McQuillan, J. J., & Dean, D. C. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.9.3943 · Cited by 86
ACE Inhibition Versus Angiotensin Type 1 Receptor Antagonism
Brown, N. J., Kumar, S., Painter, C., & Vaughan, D. E. (2002) · Hypertension · doi:10.1161/01.hyp.0000040264.15961.48 · Cited by 80
Dimethyl sulfoxide modulates NF-kappa B and cytokine activation in lipopolysaccharide-treated murine macrophages
Kelly, K. A., Hill, M. R., Youkhana, K., Wanker, F., & Gimble, J. M. (1994) · Infection and Immunity · doi:10.1128/iai.62.8.3122-3128.1994 · Cited by 76
Plasminogen Activator Inhibitor Type-1 Synthesis and mRNA Expression in HepG2 Cells Are Regulated by VLDL
Sironi, L., Mussoni, L., Prati, L., Baldassarre, D., Camera, M., Banfi, C., & Tremoli, E. (1996) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.16.1.89 · Cited by 74
Effect of pravastatin on plasma markers of inflammation and peripheral endothelial function in male heart transplant recipients
Holm, T., Andreassen, A. K., Ueland, T., KJEKSHUS, J. K., Frøland, S. S., Kjekshus, E., Simonsen, S., Aukrust, P., & Gullestad, L. L. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(00)01516-2 · Cited by 73
Losartan and perindopril effects on plasma plasminogen activator inhibitor-1 and fibrinogen in hypertensive type 2 diabetic patients
Fogari, R., Mugellini, A., Zoppi, A., Corradi, L., Preti, P. S., Lazzari, P., & Derosa, G. (2002) · American Journal of Hypertension · doi:10.1016/s0895-7061(01)02340-8 · Cited by 70
Progression of coronary artery disease in young male post-infarction patients is linked to disturbances of carbohydrate and lipoprotein metabolism and to impaired fibrinolytic function
Båvenholm, P. (1998) · European Heart Journal · doi:10.1053/euhj.1997.0752 · Cited by 67
Fosinopril Versus Amlodipine Comparative Treatments Study
Pahor, M., Franse, L. V., Deitcher, S. R., Cushman, W. C., Johnson, K., Shorr, R. I., Kottke‐Marchant, K., Tracy, R. P., Somes, G. W., & Applegate, W. B. (2002) · Circulation · doi:10.1161/hc0402.102929 · Cited by 66
High adenoviral loads stimulate NFκB-dependent gene expression in human vascular smooth muscle cells
Clesham, G., Adam, P., Proudfoot, D., Flynn, P., Efstathiou, S., & Weissberg, P. (1998) · Gene Therapy · doi:10.1038/sj.gt.3300576 · Cited by 66
Differential effects of ACE-inhibition and angiotensin II antagonism on fibrinolysis and insulin sensitivity in hypertensive postmenopausal women
Fogari, R. (2001) · American Journal of Hypertension · doi:10.1016/s0895-7061(01)02140-9 · Cited by 65
Inhibition of Phorbol Ester-Induced Cellular Adhesion by Competitive Binding of NF-κB In Vivo
Eck, S. L., Perkins, N. D., Carr, D. P., & Nabel, G. J. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.10.6530-6536.1993 · Cited by 64
Hyperglycemia induces PAI-1 gene expression in adipose tissue by activation of the hexosamine biosynthetic pathway
Gabriely, I., Yang, X. M., Cases, J. A., Xiao, H., Rossetti, L., & Barzilai, N. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(01)00574-3 · Cited by 62
Troglitazone Improves Endothelial Dysfunction in Patients with Insulin Resistance
Watanabe, Y., Sunayama, S., Shimada, K., Sawano, M., Hoshi, S.-I., Iwama, Y., Mokuno, H., Daida, H., & Yamaguchi, H. (2000) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat1994.7.159 · Cited by 60
STAT5 Induces Macrophage Differentiation of M1 Leukemia Cells Through Activation of IL-6 Production Mediated by NF-κB p65
Kawashima, T., Murata, K., Akira, S., Tonozuka, Y., Minoshima, Y., Feng, S., Kumagai, H., Tsuruga, H., Ikeda, Y., Asano, S., et al. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.7.3652 · Cited by 57
INVOLVEMENT OF NF-κB p50/p65 HETERODIMER IN ACTIVATION OF THE HUMAN PRO-INTERLEUKIN-1β GENE AT TWO SUBREGIONS OF THE UPSTREAM ENHANCER ELEMENT
Goto, M., Katayama, K., Shirakawa, F., & Tanaka, I. (1999) · Cytokine · doi:10.1006/cyto.1998.0390 · Cited by 57
Relationship between Changes in Serum Leptin Levels and Blood Pressure after Weight Loss.
Itoh, K., Katsumi, I. M. A. I., Masuda, T., Abe, S., Tanaka, M., Koga, R., Itoh, H., MATSUYAMA, T., & Nakamura, M. (2002) · Hypertension Research · doi:10.1291/hypres.25.881 · Cited by 57
Increasing Insulin Sensitivity Lowers Blood Pressure in the Fructose-Fed Rat
Kotchen, T. A. (1997) · American Journal of Hypertension · doi:10.1016/s0895-7061(97)00164-7 · Cited by 55
hsCRP and HDL Effects of Statins Trial (CHEST): Rapid Effect of Statin Therapy on C-Reactive Protein and High-Density Lipoprotein Levels
Ansell, B. J., Watson, K. E., Weiss, R. E., & Fonarow, G. C. (2003) · Heart Disease · doi:10.1097/01.hdx.0000050407.62572.de · Cited by 52
High Glucose Induces Enhanced Monocyte Adhesion to Valvular Endothelial Cells Via a Mechanism Involving ICAM-1, VCAM-1 and CD18
Mânduțeanu, I., Voinea, M., Şerban, G., & Simionescu, M. (1999) · Endothelium · doi:10.3109/10623329909078498 · Cited by 49
Aspirin in the treatment of cardiovascular disease: A review
Mustard, J. F., Kinlough-Rathbone, R. L., & Packham, M. A. (1983) · The American Journal of Medicine · doi:10.1016/0002-9343(83)90527-2 · Cited by 45
Troglitazone reduces plasma levels of tumour necrosis factor‐α in obese patients with type 2 diabetes
Katsuki, A., Sumida, Y., Murata, K., Furuta, M., Araki-Sasaki, R., Tsuchihashi, K., Hori, Y., Yano, Y., Gabazza, E. C., & Adachi, Y. (2000) · Diabetes Obesity and Metabolism · doi:10.1046/j.1463-1326.2000.00072.x · Cited by 43
Effect of Nitric Oxide Donors on Neointima Formation and Vascular Reactivity in the Collared Carotid Artery of Rabbits
Meyer, G. R. Y. D., Bult, H., Üstünes, L., Kockx, M. M., Feelisch, M., & Herman, A. G. (1995) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199508000-00013 · Cited by 40
PAI-1 in human hypertension: relation to hypertensive groups
Srikumar, N., Brown, N. J., Hopkins, P. N., Jeunemaı̂tre, X., Hunt, S. C., Vaughan, D. E., & Williams, G. H. (2002) · American Journal of Hypertension · doi:10.1016/s0895-7061(02)02952-7 · Cited by 40
Improvement by the insulin-sensitizing agent, troglitazone, of abnormal fibrinolysis in type 2 diabetes mellitus
Kato, K., Yamada, D., Midorikawa, S., Sato, W., & Watanabe, T. (2000) · Metabolism · doi:10.1016/s0026-0495(00)80045-1 · Cited by 39
Non-lipid effects of statin on hypercholesterolemic patients established to have coronary artery disease who remained hypercholesterolemic while eating a step-II diet 1
Koh, K. K., Son, J. W., Ahn, J. Y., Choi, Y. M., Jin, D., Park, G. S., Choi, I. S., Sohn, M. S., & Shin, E. K. (2001) · Coronary Artery Disease · doi:10.1097/00019501-200106000-00006 · Cited by 36
CHD: a major burden in type 2 diabetes
Nesto, R. W. (2001) · Acta Diabetologica · doi:10.1007/s005920170002 · Cited by 28

Flagged first, then by citations

3 of the 121 references couldn’t be matched to a known paper.

Sorted by citations

The Metabolic Syndrome
Cornier, M.-A., Dabelea, D., Hernandez, T. L., Lindstrom, R. C., Steig, A. J., Stob, N. R., Van Pelt, R. E., Wang, H., & Eckel, R. H. (2008) · Endocrine Reviews · doi:10.1210/er.2008-0024 · Cited by 2,162
Comparison of the Release of Adipokines by Adipose Tissue, Adipose Tissue Matrix, and Adipocytes from Visceral and Subcutaneous Abdominal Adipose Tissues of Obese Humans
Fain, J. N., Madan, A. K., Hiler, M. L., Cheema, P. S., & Bahouth, S. W. (2004) · Endocrinology · doi:10.1210/en.2003-1336 · Cited by 1,619
“• Adipokine Release by Human Adipose Tissue Endocrinology, May 2004, 145(5):2273–2282 2275”
BackgroundInfluential
Obesity-Induced Hypertension: Interaction of Neurohumoral and Renal Mechanisms
Hall, J. E., do Carmo, J. M., da Silva, A. A., Wang, Z., & Hall, M. E. (2015) · Circulation Research · doi:10.1161/circresaha.116.305697 · Cited by 1,360
A Paracrine Loop Between Adipocytes and Macrophages Aggravates Inflammatory Changes: Role of Free Fatty Acids and Tumor Necrosis Factor α
Suganami, T., Nishida, J., & Ogawa, Y. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000183883.72263.13 · Cited by 1,056
Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-α and IL-6
Park, H. S., Park, J. Y., & Yu, R. (2005) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2004.11.007 · Cited by 964

See all 761

Authors: Lyon, C. J., Law, R. E., & Hsueh, W. A.
Affiliations: University of California, Los Angeles (US)
Corresponding author: Hsueh, Willa A.
ORCID: Lyon, Christopher J.
Hsueh, Willa A.
Venue: Endocrinology
Publisher: The Endocrine Society
Published: 2003-06-01
Volume: 144
Issue: 6
Pages: 2195-2200
ISSN: 0013-7227 (ISSN-L)
1945-7170
DOI: 10.1210/en.2003-0285
OpenAlex: W1981444005
Cited by: 761
References: 121
Citations by year: 2026: 6 · 2025: 4 · 2024: 7 · 2023: 11 · 2022: 15 · 2021: 12 · 2020: 16 · 2019: 42 · 2018: 23 · 2017: 31 · 2016: 20 · 2015: 39 · 2014: 31 · 2013: 31 · 2012: 37
FWCI: 9.73
Type: journal article
Language: en
Open access: closed
Locations: Endocrinology (publishedVersion)
PubMed (publishedVersion)
Funders: National Heart, Lung, and Blood Institute (1P01 HIG0030-01A1)
Topics: Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
Keywords: adiposity, adipokines, atherosclerosis, vascular inflammation, visceral adipose tissue, obesity, insulin resistance, hypertension, endothelial dysfunction, vascular remodeling, bariatric surgery, physical activity, caloric restriction, anti-inflammatory agents, hypercholesterolemia
MeSH terms: Adipose Tissue, Animals, Arteriosclerosis, Humans, Obesity, Vasculitis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Minireview: Adiposity, Inflammation, and Atherogenesis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks